22/09/2010 (Agence Europe) - On 22 September, the European Commission approved the proposed acquisition by Deutsche Bank (Frankfurt, Germany) of control over the Icelandic generic pharmaceutical company Actavis. Through the proposed transaction, Deutsche Bank, which is Actavis's most important creditor, will acquire control over Actavis due to rights reserved to Deutsche Bank following a financial restructuring. The Commission's investigation, under the normal procedure, did not reveal any...